Association of PD-L1 Expression and Other Variables With Benefit From ICI Therapy in Advanced Gastroesophageal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer: Systematic Review and Meta-analysis of 17 Phase 3 Randomized Clinical Trials
JAMA Oncol 2022 Aug 25;[EPub Ahead of Print], HH Yoon, Z Jin, O Kour, LA Kankeu Fonkoua, K Shitara, MK Gibson, LJ Prokop, M Moehler, YK Kang, Q Shi, JA AjaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.